AnaptysBio is a biotech company that specializes in developing therapeutic candidates for inflammation and immuno-oncology illnesses, including Imsidolimab, Rosnilimab and ANB032. They are also engaged in pre-clinical antibody programs under various collaborations and agreements with companies such as GlaxoSmithKline Inc and Bristol-Myers Squibb. The company is based in San Diego, California.